What amount sold does Galenus Precision Pharmacy, Inc. report in Form D filings?

The latest linked filings report $7.3M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Galenus Precision Pharmacy, Inc.'s most recent SEC filing?

Galenus Precision Pharmacy, Inc.'s most recent Form D filing was on 2026-02-18.

How many investors does Galenus Precision Pharmacy, Inc. have?

The most recent Form D filing lists 3 investor(s).

What type of securities does Galenus Precision Pharmacy, Inc. offer?

Galenus Precision Pharmacy, Inc.'s SEC Form D filings indicate equity offerings.

Galenus Precision Pharmacy, Inc.

CIK: 0002107049·Pharmaceuticals·MT. LAUREL, NJ·Limited Partnership·Founded 2025

Reported Sold

$7,340,499

Total Filings

Identified Offerings

Last Filed

Feb 18, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Feb 18, 2026Form D — New notice

Reported sold: $1,940,500 · Target: $2,817,250

Rule 506(b)·20 investors

Feb 18, 2026Form D — New notice

Reported sold: $5,399,999 · Target: $6,599,999

Rule 506(b)·3 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$7,340,499

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Calvin H. Knowlton

Related Person

Appears on 2 filings

Orsula V. Knowlton

Related Person

Appears on 2 filings

Jarred Bressner

Related Person

Appears on 2 filings

Saul Richter

Related Person

Appears on 2 filings

Dennis Helling

Related Person

Appears on 2 filings

Samira Beckwith

Related Person

Appears on 2 filings

Gordon Tunstall

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 18, 2026	New	$6,599,999	$5,399,999	3
Feb 18, 2026	New	$2,817,250	$1,940,500	20

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Crosslink Therapeutics Inc.

Pharmaceuticals

Offering target: $5,500,000

Filed Oct 20, 2026